Sergio A Jimenez
Overview
Explore the profile of Sergio A Jimenez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
3830
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Somashekar A, Squires S, Benedetto A, Griffin T, Jimenez S, Mendoza F
Am J Med Sci
. 2024 Sep;
PMID: 39326737
Nodular scleroderma is a rare variant of systemic sclerosis (SSc) characterized by fleshy, indurated nodules commonly distributed over the upper and lower extremities and in the trunk. Most scientific publications...
2.
Piera-Velazquez S, Fortina P, Jimenez S
Clin Exp Rheumatol
. 2024 Aug;
42(8):1629-1634.
PMID: 39152754
Objectives: To compare the microRNAs (miRNAs) contained within serum exosomes isolated from patients with Raynaud's phenomenon (RP) and negative antinuclear antibodies (ANA) to the miRNA contained in serum exosomes isolated...
3.
Hitraya E, Gaidarova S, Piera-Velazquez S, Jimenez S
Connect Tissue Res
. 2024 Mar;
65(2):161-169.
PMID: 38436275
Objective: The COL1A1 proximal promoter contains two GC-rich regions and two inverted CCAAT boxes. The transcription factors Sp1 and CBF bind to the GC sequence at -122 to -115 bp...
4.
Jimenez S, Piera-Velazquez S
Curr Rheumatol Rev
. 2023 Nov;
20(4):388-404.
PMID: 37921216
Systemic Sclerosis (SSc) is a systemic autoimmune disease of unknown etiology with a highly complex pathogenesis that despite extensive investigation is not completely understood. The clinical and pathologic manifestations of...
5.
Mendoza F, Allawh T, Jimenez S
Clin Exp Rheumatol
. 2023 Jun;
41(8):1704-1712.
PMID: 37382458
Interstitial lung disease (ILD) has a high prevalence among patients with systemic sclerosis (SSc), carrying high mortality and morbidity. During the last decade, the emergence of new pharmacological therapies for...
6.
Piera-Velazquez S, Dillon S, Gu X, Libermann T, Jimenez S
PLoS One
. 2022 Dec;
17(12):e0279461.
PMID: 36548367
Background: A major unmet need for Systemic Sclerosis (SSc) clinical management is the lack of biomarkers for the early diagnosis of patients with Raynaud's Phenomenon at high risk of evolving...
7.
Mendoza F, DiMarino A, Cohen S, Adkins C, Abdelbaki S, Rattan S, et al.
J Clin Med
. 2022 Nov;
11(22).
PMID: 36431141
Oropharyngeal and esophageal dysmotility can cause serious clinical complications such as aspiration pneumonia, cachexia, and sarcopenia, with a resulting increase in mortality and disability. The current standard of care for...
8.
Jimenez S, Piera-Velazquez S
Rheumatology (Oxford)
. 2022 Aug;
62(3):999-1008.
PMID: 35944210
SSc is a systemic autoimmune disease of unknown etiology characterized by frequently progressive cutaneous and internal organ fibrosis causing severe disability, organ failure and high mortality. A remarkable feature of...
9.
Mendoza F, Bagley J, Gochfeld M, Dalakas M, Farber J, Jimenez S
Acta Neuropathol Commun
. 2022 Mar;
10(1):34.
PMID: 35296359
Entrapment peripheral neuropathies are clinically characterized by sensory impairment and motor deficits. They are usually caused by mechanical injuries, but they are also a frequent manifestation of metabolic diseases, toxic...
10.
Piera-Velazquez S, Jimenez S
J Clin Med
. 2021 Oct;
10(20).
PMID: 34682914
Numerous clinical and research investigations conducted during the last two decades have implicated excessive oxidative stress caused by high levels of reactive oxygen species (ROS) in the development of the...